_id

690dafd2ccc777a4e85d0b2f

Ticker

APLS

Name

Apellis Pharmaceuticals Inc

Exchange

NASDAQ

Address

100 Fifth Avenue, Waltham, MA, United States, 02451

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://apellis.com

Description

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria; and SYFOVRE for treating geographic atrophy secondary to age-related macular degeneration and geographic atrophy (GA). The company also develops EMPAVELI to treat C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, hematopoietic stem cell transplantation-associated thrombotic microangiopathy, focal segmental glomerulosclerosis, and delayed graft function; and APL-3007, a small interfering RNA, or siRNA for the treatment of GA. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

Last Close

24.965

Volume

1827204

Current Price

25.23

Change

1.0614860805127202

Last Updated

2025-11-28T12:18:18.643Z

Image

data:image/webp;base64,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

Ipo Date

2017-11-09T00:00:00.000Z

Market Cap

2731679488

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9341333333333334

Sentiment Sources

15

Rating

4.0909

Target Price

35.3889

Strong Buy

10

Buy

4

Hold

8

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

458578000

Cost Of Revenue

24531000

Gross Profit

434047000

Operating Expenses

210864000

Operating Income

223183000

Interest Expense

11279000

Pretax Income

216317000

Net Income

215715000

Eps

1.7116977718529804

Dividends Per Share

-

Shares Outstanding

126525218

Income Tax Expense

602000

EBITDA

227935000

Operating Margin

48.66849260104061

Total Other Income Expense Net

-6866000

Cash

479171000

Short Term Investments

-

Receivables

354635000

Inventories

122819000

Total Current Assets

990676000

Property Plant Equipment

21647000

Total Assets

1058723000

Payables

38602000

Short Term Debt

100603000

Long Term Debt

361091000

Total Liabilities

657555000

Equity

401168000

Depreciation

339000

Change In Working Capital

-136408000

Cash From Operations

108468000

Capital Expenditures

148000

Cash From Investing

-148000

Cash From Financing

793000

Net Change In Cash

109135000

PE

59.9722

PB

7.925820404419096

ROE

53.77173652933435

ROA

20.375017828081564

FCF

108320000

Fcf Percent

0.23620845308758814

Piotroski FScore

3

Health Score

75

Deep Value Investing Score

4.5

Defensive Investing Score

5.5

Dividend Investing Score

3

Economic Moat Investing Score

9

Garp Investing Score

6.5

Growth Investing Score

6

Momentum Investing Score

3

Net Net Investing Score

2.5

Quality Investing Score

9

Value Investing Score

5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

458578000

Quarters > 0 > income Statement > cost Of Revenue

24531000

Quarters > 0 > income Statement > gross Profit

434047000

Quarters > 0 > income Statement > operating Expenses

210864000

Quarters > 0 > income Statement > operating Income

223183000

Quarters > 0 > income Statement > interest Expense

11279000

Quarters > 0 > income Statement > pretax Income

216317000

Quarters > 0 > income Statement > net Income

215715000

Quarters > 0 > income Statement > eps

1.7116977718529804

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

126024000

Quarters > 0 > income Statement > income Tax Expense

602000

Quarters > 0 > income Statement > EBITDA

227935000

Quarters > 0 > income Statement > operating Margin

48.66849260104061

Quarters > 0 > income Statement > total Other Income Expense Net

-6866000

Quarters > 0 > balance Sheet > cash

479171000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

354635000

Quarters > 0 > balance Sheet > inventories

122819000

Quarters > 0 > balance Sheet > total Current Assets

990676000

Quarters > 0 > balance Sheet > property Plant Equipment

21647000

Quarters > 0 > balance Sheet > total Assets

1058723000

Quarters > 0 > balance Sheet > payables

38602000

Quarters > 0 > balance Sheet > short Term Debt

100603000

Quarters > 0 > balance Sheet > long Term Debt

361091000

Quarters > 0 > balance Sheet > total Liabilities

657555000

Quarters > 0 > balance Sheet > equity

401168000

Quarters > 0 > cash Flow > net Income

215715000

Quarters > 0 > cash Flow > depreciation

339000

Quarters > 0 > cash Flow > change In Working Capital

-136408000

Quarters > 0 > cash Flow > cash From Operations

108468000

Quarters > 0 > cash Flow > capital Expenditures

148000

Quarters > 0 > cash Flow > cash From Investing

-148000

Quarters > 0 > cash Flow > cash From Financing

793000

Quarters > 0 > cash Flow > net Change In Cash

109135000

Quarters > 0 > ratios > PE

1.7116977718529804

Quarters > 0 > ratios > PB

7.925820404419096

Quarters > 0 > ratios > ROE

53.77173652933435

Quarters > 0 > ratios > ROA

20.375017828081564

Quarters > 0 > ratios > FCF

108320000

Quarters > 0 > ratios > Piotroski FScore

3

Quarters > 0 > ratios > fcf Percent

0.23620845308758814

Quarters > 0 > health Score

75

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

178494000

Quarters > 1 > income Statement > cost Of Revenue

14072000

Quarters > 1 > income Statement > gross Profit

164422000

Quarters > 1 > income Statement > operating Expenses

197708000

Quarters > 1 > income Statement > operating Income

-33286000

Quarters > 1 > income Statement > interest Expense

11152000

Quarters > 1 > income Statement > pretax Income

-41685000

Quarters > 1 > income Statement > net Income

-42151000

Quarters > 1 > income Statement > eps

-0.33446803783406337

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

126024000

Quarters > 1 > income Statement > income Tax Expense

466000

Quarters > 1 > income Statement > EBITDA

-30087000

Quarters > 1 > income Statement > operating Margin

-18.648245879413313

Quarters > 1 > income Statement > total Other Income Expense Net

-8399000

Quarters > 1 > balance Sheet > cash

371466000

Quarters > 1 > balance Sheet > short Term Investments

4746000

Quarters > 1 > balance Sheet > receivables

229227000

Quarters > 1 > balance Sheet > inventories

121000000

Quarters > 1 > balance Sheet > total Current Assets

755610000

Quarters > 1 > balance Sheet > property Plant Equipment

16754000

Quarters > 1 > balance Sheet > total Assets

821390000

Quarters > 1 > balance Sheet > payables

54241000

Quarters > 1 > balance Sheet > short Term Debt

7419000

Quarters > 1 > balance Sheet > long Term Debt

454035000

Quarters > 1 > balance Sheet > total Liabilities

665085000

Quarters > 1 > balance Sheet > equity

156305000

Quarters > 1 > cash Flow > net Income

-42151000

Quarters > 1 > cash Flow > depreciation

446000

Quarters > 1 > cash Flow > change In Working Capital

18339000

Quarters > 1 > cash Flow > cash From Operations

4445000

Quarters > 1 > cash Flow > capital Expenditures

49000

Quarters > 1 > cash Flow > cash From Investing

-49000

Quarters > 1 > cash Flow > cash From Financing

6558000

Quarters > 1 > cash Flow > net Change In Cash

11639000

Quarters > 1 > ratios > PE

-0.33446803783406337

Quarters > 1 > ratios > PB

20.342186878218868

Quarters > 1 > ratios > ROE

-26.967147564057452

Quarters > 1 > ratios > ROA

-5.131667052192016

Quarters > 1 > ratios > FCF

4396000

Quarters > 1 > ratios > Piotroski FScore

2

Quarters > 1 > ratios > fcf Percent

0.02462827882169709

Quarters > 1 > health Score

10

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

166797000

Quarters > 2 > income Statement > cost Of Revenue

34360000

Quarters > 2 > income Statement > gross Profit

132437000

Quarters > 2 > income Statement > operating Expenses

215765000

Quarters > 2 > income Statement > operating Income

-83328000

Quarters > 2 > income Statement > interest Expense

11049000

Quarters > 2 > income Statement > pretax Income

-91884000

Quarters > 2 > income Statement > net Income

-92225000

Quarters > 2 > income Statement > eps

-0.7351358676157604

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

125453000

Quarters > 2 > income Statement > income Tax Expense

341000

Quarters > 2 > income Statement > EBITDA

-80389000

Quarters > 2 > income Statement > operating Margin

-49.957733052752744

Quarters > 2 > income Statement > total Other Income Expense Net

-8556000

Quarters > 2 > balance Sheet > cash

358393000

Quarters > 2 > balance Sheet > short Term Investments

3942000

Quarters > 2 > balance Sheet > receivables

244377000

Quarters > 2 > balance Sheet > inventories

82468000

Quarters > 2 > balance Sheet > total Current Assets

727718000

Quarters > 2 > balance Sheet > property Plant Equipment

17765000

Quarters > 2 > balance Sheet > total Assets

807285000

Quarters > 2 > balance Sheet > payables

55287000

Quarters > 2 > balance Sheet > short Term Debt

6944000

Quarters > 2 > balance Sheet > long Term Debt

453422000

Quarters > 2 > balance Sheet > total Liabilities

643069000

Quarters > 2 > balance Sheet > equity

164216000

Quarters > 2 > cash Flow > net Income

-92225000

Quarters > 2 > cash Flow > depreciation

446000

Quarters > 2 > cash Flow > change In Working Capital

10404000

Quarters > 2 > cash Flow > cash From Operations

-53410000

Quarters > 2 > cash Flow > capital Expenditures

8000

Quarters > 2 > cash Flow > cash From Investing

-8000

Quarters > 2 > cash Flow > cash From Financing

274000

Quarters > 2 > cash Flow > net Change In Cash

-52785000

Quarters > 2 > ratios > PE

-0.7351358676157604

Quarters > 2 > ratios > PB

19.274487199785646

Quarters > 2 > ratios > ROE

-56.160788230135914

Quarters > 2 > ratios > ROA

-11.424094340908105

Quarters > 2 > ratios > FCF

-53418000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.32025755858918326

Quarters > 2 > health Score

9

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

212528000

Quarters > 3 > income Statement > cost Of Revenue

40856000

Quarters > 3 > income Statement > gross Profit

171672000

Quarters > 3 > income Statement > operating Expenses

197836000

Quarters > 3 > income Statement > operating Income

-26164000

Quarters > 3 > income Statement > interest Expense

11534000

Quarters > 3 > income Statement > pretax Income

-36067000

Quarters > 3 > income Statement > net Income

-36353000

Quarters > 3 > income Statement > eps

-0.29339650051652894

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

123904000

Quarters > 3 > income Statement > income Tax Expense

286000

Quarters > 3 > income Statement > EBITDA

-24086000

Quarters > 3 > income Statement > operating Margin

-12.310848452909735

Quarters > 3 > income Statement > total Other Income Expense Net

-9903000

Quarters > 3 > balance Sheet > cash

411290000

Quarters > 3 > balance Sheet > short Term Investments

4847000

Quarters > 3 > balance Sheet > receivables

271723000

Quarters > 3 > balance Sheet > inventories

82484000

Quarters > 3 > balance Sheet > total Current Assets

788954000

Quarters > 3 > balance Sheet > property Plant Equipment

19035000

Quarters > 3 > balance Sheet > total Assets

885051000

Quarters > 3 > balance Sheet > payables

38572000

Quarters > 3 > balance Sheet > short Term Debt

6753000

Quarters > 3 > balance Sheet > long Term Debt

452830000

Quarters > 3 > balance Sheet > total Liabilities

656512000

Quarters > 3 > balance Sheet > equity

228539000

Quarters > 3 > cash Flow > net Income

-36353000

Quarters > 3 > cash Flow > depreciation

447000

Quarters > 3 > cash Flow > change In Working Capital

28365000

Quarters > 3 > cash Flow > cash From Operations

19360000

Quarters > 3 > cash Flow > capital Expenditures

20000

Quarters > 3 > cash Flow > cash From Investing

-20000

Quarters > 3 > cash Flow > cash From Financing

-4000000

Quarters > 3 > cash Flow > net Change In Cash

14375000

Quarters > 3 > ratios > PE

-0.29339650051652894

Quarters > 3 > ratios > PB

13.678619054078297

Quarters > 3 > ratios > ROE

-15.906694262248456

Quarters > 3 > ratios > ROA

-4.107446915488485

Quarters > 3 > ratios > FCF

19340000

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

0.09099977414740645

Quarters > 3 > health Score

21

Valuation > metrics > PE

59.9722

Valuation > metrics > PB

7.925820404419096

Valuation > final Score

1

Valuation > verdict

152.0% Overvalued

Profitability > metrics > ROE

53.77173652933435

Profitability > metrics > ROA

21.77452567741623

Profitability > metrics > Net Margin

0.47039980112434526

Profitability > final Score

100

Profitability > verdict

Adequate

Risk > metrics > Debt Equity

1.6391013241335302

Risk > metrics > Interest Coverage

19.787481159677277

Risk > final Score

70

Risk > verdict

Low

Liquidity > metrics > Current Ratio

7.116669659854172

Liquidity > metrics > Quick Ratio

6.234380948960166

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-6

Prev Risks > 1

-24

Prev Risks > 2

9

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:14:01.144Z